spacer
home > pmps > summer 2017 > new environments
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Environments

Current biologic, pharmaceutical and emerging personalised medicine development environments are rapidly evolving. Production processes, including single-use, continuous and new therapy modalities, are driving commercial operations to evolve quickly to keep pace. Strategic partners are working to integrate key technologies, allowing stakeholders to realise the promise of Industry 4.0.

The pharma sector has always been challenged to swiftly innovate while staying within regulatory compliance boundaries. Inside product development and clinical or commercial manufacturing disciplines, this field is again being asked to acquire, contextualise and deliver data from sources in ways once thought too expensive or technically challenging to achieve.

The future of the Industrial Internet of Things (IIoT) is extremely promising, with an estimated potential benefit of $1 trillion. This kind of figure is astounding, but how can manufacturers get started with capturing some of this value? Rather than looking to revolutionise business by transforming the entire infrastructure model, many companies are seeing results by starting small and focusing on specific problems that have been difficult to solve with existing methods. Leveraging technologies currently in use has allowed organisations to begin delivering quality.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jeff Hackney is a Life Sciences Business Leader at Emerson. He focuses on combining technology and strategy into successful customer-focused solutions for global manufacturers in the industry. He has spent 30 years in automation, split between the US Navy and Emerson where he has served the life sciences industry at Emerson for the last nine years. Jeff holds a Bachelor of Science in IT, and his previous areas of automation specialisation include operator training and simulation. 

Mike Boudreaux is Director of Connected Services at Emerson. Prior to his current role, he held various positions in engineering, product management, marketing and sales at Emerson, Alcoa and AkzoNobel. Mike is a widely published author in the process industries and specialises in developing IIoT-enabled automation solutions for organisations in the life sciences, power, oil and gas, refining and chemicals industries. He holds a Bachelor of Science in chemical engineering from the University of Houston, US, and an MBA from the Kellogg School of Management at Northwestern University, US. 

spacer
Jeff Hackney
spacer
spacer
spacer
Mike Boudreaux
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mironid Announces Closing of £4.3 million ($6.2 million) Series A Financing

Cell signalling in drug development company today announced the closure of its Series A funding round
More info >>

White Papers

Case Study: Molly™ Auto Injector

SHL Group

The Molly™ Auto Injector is a revolutionary, ultra-compact device, designed for convenience and portability. With the handling process reduced to only 2 simple steps— uncap and inject — Molly™ is incredibly intuitive to use, and quickly became a new benchmark for the auto injector industry. In addition to the many enhanced features that benefit patients, Molly™ was also uniquely designed to offer an alternative business model for customers, one that allowed them to minimize initial investments while maximizing speed-to-market.
More info >>

 
Industry Events

Global Bioproduction Summit, 5th-6th February 2018

5-6 February 2018, Hilton San Diego Resort & Spa, CA

After 15 years in Europe, the Global Bioproduction Summit moved to its new home of San Diego in 2016. The Bioproduction Summit delves deep into the world of biological production.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement